Richard R. DeLuca, EVP&Pres, Merck Animal Heallth at Merck & Co., Inc. (MRK), sold 87,646 shares at $105.03 ($9.2M) on 2023-11-08, disclosed to the SEC on 2023-11-09.
Open-market sale of $9.2M MRK by EVP&Pres, Merck Animal Heallth. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $105.03 | 43,823 | $4.6M | 50.0% |
| 2 | $105.03 | 43,823 | $4.6M | 50.0% |
| Total | $105.03 avg | 87,646 | $9.2M | 100% |
| Filing → |
| MRK | SELL | 2026-02-06 | $4.6M | — | Filing → |
| MRK | SELL | 2023-05-02 | $25.1M | — | Filing → |
| MRK | SELL | 2022-11-01 | $33.0M | — | Filing → |